Tuesday - April 21, 2026

Category Archives: Science

Codex Labs Showcases Integrative Skin-Gut-Brain Solutions at 2026 CNDA Conference

LONG BEACH, Calif. – April 13, 2026 – Codex Labs, a biotech skincare company focused on integrative dermatology and microbiome-friendly skin-gut solutions, is honored to participate in the California Naturopathic Doctors Association’s (CNDA) annual conference. The world’s top Naturopathic Doctors … Continue reading →

Graves’ Disease Treatment Market Size in the 7MM was ~ USD 4,400 million in 2023 and It is projected to grow by 2034, estimates DelveInsight

DelveInsight’s “Graves’ Disease Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Graves’ Disease, historical and forecasted epidemiology as well as the Graves’ Disease market trends in the United States, EU4 (Germany, Spain, Italy, France) the … Continue reading →

Head and Neck Cancer Clinical Trial Pipeline Expands as 80+ Companies Driving Innovation in the Therapeutics | DelveInsight

DelveInsight’s “Head and Neck Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Head and Neck Cancer pipeline landscape. It covers the Head and Neck Cancer Pipeline drug profiles, including clinical and … Continue reading →

Metastatic Castration-Resistant Prostate Cancer Clinical Trial Pipeline Shows Potential with Active Contributions from 75+ Key Companies | DelveInsight

DelveInsight’s, “Metastatic Castration-Resistant Prostate Cancer Pipeline Insights 2026” report provides comprehensive insights about 75+ companies and 75+ pipeline drugs in the Metastatic Castration-Resistant Prostate Cancer pipeline landscape. It covers the Metastatic Castration-Resistant Prostate Cancer pipeline drug profiles, including clinical and … Continue reading →

Vascular Dementia Clinical Trial Pipeline Accelerates as 11+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Vascular Dementia Pipeline Insights 2026” report provides comprehensive insights about 11+ companies and 11+ pipeline drugs in Vascular Dementia pipeline landscape. It covers the Vascular Dementia pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Acute On Chronic Liver Failure Clinical Trial Pipeline Gains Momentum: 3+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Acute On Chronic Liver Failure Pipeline Insight 2026” report provides comprehensive insights about 3+ companies and 5+ pipeline drugs in the Acute On Chronic Liver Failure pipeline landscape. It covers the Acute On Chronic Liver Failure pipeline drug profiles, … Continue reading →

Pneumococcal Infections Clinical Trial Pipeline Shows Potential with Active Contributions from 15+ Key Companies | DelveInsight

DelveInsight’s, “Pneumococcal infections Pipeline Insights 2026” Report provides comprehensive insights about 15+ companies and 20+ pipeline drugs in Pneumococcal infections pipeline landscape. It covers the Pneumococcal infections pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Fabry Disease Market Set for Robust Growth by 2034, Driven by Gene Therapy Breakthroughs and Expanding Pipeline from Sangamo, Sanofi, Amicus & Emerging Innovators | DelveInsight

Fabry Disease Market Fabry Disease Companies include Chiesi and Protalix Biotherapeutics, Sanofi Genzyme, Sangamo Therapeutics, Protalix Biotherapeutics, AVROBIO, Sanofi Genzyme, Sangamo Therapeutics, Freeline Therapeutics, 4D Molecular Therapeutics, Idorsia Pharmaceuticals, Greenovation Biotech GMBH, ICON plc, Chiesi Farmaceutici S.p.A., Amicus Therapeutics, Shire, … Continue reading →

Bladder Cancer Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Domain | DelveInsight

DelveInsight’s “Bladder Cancer Pipeline Insight 2026” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in the Bladder cancer pipeline landscape. It covers the Bladder Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →